WHITTIER TRUST CO has added 126,835 shares of $DHR to their portfolio, per a new SEC 13F filing. This disclosure reflects the funds' holdings for the 09-30-2025 report period. You can see the fund's full portfolio on Quiver Quantitative, and also track the largest institutional owners of $DHR.
DANAHER Hedge Fund Activity
We have seen 949 institutional investors add shares of DANAHER stock to their portfolio, and 1,088 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- PRICE T ROWE ASSOCIATES INC /MD/ removed 2,976,077 shares (-15.2%) from their portfolio in Q2 2025, for an estimated $587,894,250
- EAGLE CAPITAL MANAGEMENT LLC added 2,859,518 shares (+inf%) to their portfolio in Q2 2025, for an estimated $564,869,185
- MARSHALL WACE, LLP removed 2,761,062 shares (-76.6%) from their portfolio in Q2 2025, for an estimated $545,420,187
- CITADEL ADVISORS LLC removed 2,549,058 shares (-96.7%) from their portfolio in Q2 2025, for an estimated $503,540,917
- VIKING GLOBAL INVESTORS LP added 2,455,994 shares (+543.9%) to their portfolio in Q2 2025, for an estimated $485,157,054
- GENERATION INVESTMENT MANAGEMENT LLP added 1,787,522 shares (+56.2%) to their portfolio in Q2 2025, for an estimated $353,107,095
- INVESCO LTD. removed 1,625,047 shares (-34.5%) from their portfolio in Q2 2025, for an estimated $321,011,784
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
DANAHER Insider Trading Activity
DANAHER insiders have traded $DHR stock on the open market 9 times in the past 6 months. Of those trades, 0 have been purchases and 9 have been sales.
Here’s a breakdown of recent trading of $DHR stock by insiders over the last 6 months:
- STEVEN M RALES (Chairman) has made 0 purchases and 8 sales selling 1,250,000 shares for an estimated $245,919,390.
- TERI LIST sold 2,778 shares for an estimated $586,319
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
DANAHER Government Contracts
We have seen $105,346,215 of award payments to $DHR over the last year.
Here are some of the awards which we have have seen pay out the most over the last year:
- MOLECULAR DIAGNOSTIC TESTS FOR SARS-COV-2: $3,970,565
- POLYMERASE CHAIN REACTION (PCR) DIAGNOSTIC TESTING FOR VISN 2 DOWNSTATE: $3,781,390
- AB SCIEX SERVICE & MAINTENANCE AGREEMENT SUPPORT: $3,403,150
- IN-VITRO REAGENTS - VISN 15, ORDERING PERIOD ONE: $2,898,933
- IN-VITRO REAGENTS: $2,304,881
To track government contracts to publicy traded companies, check out Quiver Quantitative's government contracts dashboard.
DANAHER Congressional Stock Trading
Members of Congress have traded $DHR stock 8 times in the past 6 months. Of those trades, 3 have been purchases and 5 have been sales.
Here’s a breakdown of recent trading of $DHR stock by members of Congress over the last 6 months:
- REPRESENTATIVE LISA C. MCCLAIN has traded it 2 times. They made 1 purchase worth up to $15,000 on 07/22 and 1 sale worth up to $15,000 on 09/25.
- REPRESENTATIVE THOMAS H. KEAN, JR. has traded it 2 times. They made 2 purchases worth up to $30,000 on 09/03, 06/11 and 0 sales.
- SENATOR SHELDON WHITEHOUSE sold up to $15,000 on 08/28.
- REPRESENTATIVE PETE SESSIONS sold up to $100,000 on 06/12.
- REPRESENTATIVE ROBERT BRESNAHAN sold up to $15,000 on 05/15.
- REPRESENTATIVE JEFFERSON SHREVE sold up to $50,000 on 05/12.
To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.
DANAHER Analyst Ratings
Wall Street analysts have issued reports on $DHR in the last several months. We have seen 8 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- Barclays issued a "Overweight" rating on 10/22/2025
- TD Cowen issued a "Buy" rating on 10/22/2025
- Evercore ISI Group issued a "Outperform" rating on 10/07/2025
- B of A Securities issued a "Buy" rating on 09/22/2025
- Baird issued a "Outperform" rating on 07/23/2025
- UBS issued a "Buy" rating on 07/23/2025
- Guggenheim issued a "Buy" rating on 07/23/2025
To track analyst ratings and price targets for DANAHER, check out Quiver Quantitative's $DHR forecast page.
DANAHER Price Targets
Multiple analysts have issued price targets for $DHR recently. We have seen 10 analysts offer price targets for $DHR in the last 6 months, with a median target of $237.5.
Here are some recent targets:
- Brandon Couillard from Wells Fargo set a target price of $230.0 on 10/23/2025
- Dan Brennan from TD Cowen set a target price of $260.0 on 10/22/2025
- Luke Sergott from Barclays set a target price of $250.0 on 10/22/2025
- Ed Ridley-Day from Rothschild & Co set a target price of $220.0 on 10/08/2025
- Vijay Kumar from Evercore ISI Group set a target price of $245.0 on 10/07/2025
- Derik De Bruin from B of A Securities set a target price of $220.0 on 09/22/2025
- Subbu Nambi from Guggenheim set a target price of $250.0 on 07/23/2025
Note that there may be inaccuracies in these estimates due to filing errors by the funds, parsing errors by us, or other anomalies.
Check out Quiver Quantitative's $DHR ticker page for more data.
